• ISSN: 2010-023X (Print)
    • Abbreviated Title: Int. J. Trade, Economics and Financ.
    • Frequency: Bimonthly
    • DOI: 10.18178/IJTEF
    • Editor-in-Chief: Prof.Tung-Zong (Donald) Chang
    • Executive Editor: Ms. Cherry L. Chen
    • Abstracting/ Indexing:  ProQuest, Crossref, Electronic Journals Library , EBSCO, and Ulrich's Periodicals Directory
    • E-mail: ijtef@ejournal.net
IJTEF 2019 Vol.10(4): 92-98 ISSN: 2010-023X
DOI: 10.18178/ijtef.2019.10.4.643

Research on the Transition and Upgrading of the Patent-Intensive Industry in China: A Case of the bio-Pharmaceutical Industry

Xia Zhou and Wentong Wang
Abstract—With the increasingly prominent role of patents in the national economy, China regards the cultivation of the patent-intensive industry as an important way to build a strong intellectual property country and implement an innovation-driven development strategy. The patent-intensive industry is a rapidly growing strategic emerging industry with strong economic driving ability and strong market competitive advantage. A patent-intensive industry refers to an industry that relies heavily on technical and intellectual factors in production processes that are more dependent on other factors of production. Among them, the bio-pharmaceutical industry has always been valued as a permanent sunrise industry by all countries in the world. As a high-tech, high-input, high-risk and high-yield patent-intensive industry, its dependence on intellectual property protection is much higher than other industries. In recent years, the bio-pharmaceutical industry in China has shown a rapid development trend,which has initially formed an industrial space pattern with the Yangtze River Delta and the Bohai Sea as the core, as well as the Pearl River Delta and the Northeast developing rapidly. However, the overall competitiveness is weak and urgently needs transition and upgrading. This paper combs the development status of the bio-pharmaceutical industry from 2010 to 2017 in China, and then analyzes current situations and characteristics of the bio-pharmaceutical industry based on the industry life cycle theory. Finally, the paper proposes countermeasures to promote the transition and upgrading of the bio-pharmaceutical industry in China.

Index Terms—China, the patent-intensive industry, the bio-pharmaceutical industry, transition and upgrading.

The authors are with the Department of Business Administration, South China University of Technology, Guangdong, CO 510641 China (e-mail: wwtmaggie@163.com, 8605340@qq.com).

[PDF]

Cite: Xia Zhou and Wentong Wang, "Research on the Transition and Upgrading of the Patent-Intensive Industry in China: A Case of the bio-Pharmaceutical Industry," International Journal of Trade, Economics and Finance vol.10, no.4, pp. 92-98, 2019.

Copyright © 2019 by the authors. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Copyright © 2008-2019. International Journal of Trade, Economics and Finance. All rights reserved.
E-mail: ijtef@ejournal.net